Feature Channels: Dermatology

Filters close
Released: 11-Jan-2023 1:05 PM EST
Green algae enhances skin regeneration to speed up healing
Wiley

A product of a freshwater single-celled green algae called Euglena gracilis may enhance skin regeneration to speed up wound healing, according to new research published in Advanced Materials Interfaces.

   
Released: 11-Jan-2023 12:45 PM EST
American Academy of Dermatology issues updated guidelines for the management of atopic dermatitis in adults with topical therapies
American Academy of Dermatology

ROSEMONT, Ill. (January 11, 2023) — Often called eczema or atopic eczema, atopic dermatitis is a common skin condition, affecting 1 in 10 Americans. Although atopic dermatitis occurs most frequently in children, it also affects adults and can have a significant impact on patients’ quality of life. To help ensure that adult patients with atopic dermatitis receive the best possible treatment, the American Academy of Dermatology (AAD) has published updated guidelines of care for the management of atopic dermatitis in adults with topical therapies in the y.

Newswise: Experts Tackle Racial Disparities Affecting People with Allergic Conditions
Released: 11-Jan-2023 10:45 AM EST
Experts Tackle Racial Disparities Affecting People with Allergic Conditions
American College of Allergy, Asthma and Immunology (ACAAI)

A special article in Annals of Allergy, Asthma and Immunology reports on the findings of a roundtable discussion that focused on challenges that people with skin of color with atopic dermatitis and food allergy often experience based on their skin type, their comfort level with health care providers, where they live, and many other sociodemographic factors.

Newswise: Study sheds novel insights on the mechanism of melanin formation
Released: 10-Jan-2023 1:40 PM EST
Study sheds novel insights on the mechanism of melanin formation
Doshisha University

The skin is presumably the largest and one of the most versatile body organs. By providing a physical barrier, it protects our body from environmental assaults.

Released: 9-Jan-2023 4:40 PM EST
Fewer cases of melanoma among people taking vitamin D supplements
University of Eastern Finland

Fewer cases of melanoma were observed among regular users of vitamin D supplements than among non-users, a new study finds.

Released: 6-Jan-2023 1:15 PM EST
Scars mended using transplanted hair follicles
Imperial College London

In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants.

Newswise: Eye scratching mechanisms in rats
Released: 27-Dec-2022 7:15 PM EST
Eye scratching mechanisms in rats
Okayama University

Anyone suffering dry skin, eczema, or insect bites will know the unpleasant effects of itchy skin.

   
Released: 21-Dec-2022 12:35 PM EST
Golden State Dermatology Expands Their Network in Sacramento
Golden State Dermatology

Golden State Dermatology (GSD) is pleased to announce a new partnership with the dermatology practice of Emil Tanghetti, MD located in Sacramento, CA. The new partnership expands GSD's network to 28 practices across the San Francisco Bay and California's Central Valley and Sacramento Valley.

8-Dec-2022 11:30 AM EST
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Mount Sinai Health System

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped

Released: 6-Dec-2022 10:05 AM EST
How to treat minor burns and cuts
American Academy of Dermatology

With the holidays upon us, kitchen accidents can become more common as we cook meals for large gatherings of friends and family. In preparation for the holiday season, a board-certified dermatologist from the American Academy of Dermatology (AAD) is sharing tips on how to treat minor burns and cuts and apply proper wound care.

Newswise: Research: Grape Consumption Helps Counter UV Damage to Skin
Released: 30-Nov-2022 3:50 PM EST
Research: Grape Consumption Helps Counter UV Damage to Skin
Academy Communications

A just-published study by Dr. John Pezzuto of the Western New England University College of Pharmacy and Health Sciences found that consuming grapes protected against ultraviolet damage to the skin.

Newswise: Researchers developing treatment for drug-resistant fungus with $3M-plus grant from National Institutes of Health
Released: 30-Nov-2022 11:05 AM EST
Researchers developing treatment for drug-resistant fungus with $3M-plus grant from National Institutes of Health
Case Western Reserve University

With a new $3 million-plus grant from the National Institutes of Health (NIH), Case Western Reserve University researchers are examining the next level of treatment for Candida auris (C.auris), a multidrug-resistant yeast that causes serious infection and, in some cases, death.

Released: 30-Nov-2022 9:45 AM EST
Texas dermatologist recognized for improving the quality of life of a child with rare condition
American Academy of Dermatology

ROSEMONT, Ill. (November 30, 2022) — Board-certified dermatologist John Browning MD, FAAD, FAAP, adjunct associate professor of pediatrics and dermatology at UT Health in San Antonio, was named an American Academy of Dermatology Patient Care Hero for his expertise in laser treatments that helped relieve his pediatric patient's pain and improve his quality of life.

Released: 29-Nov-2022 1:00 PM EST
Minor facial scars do not have negative affects on first impressions
Wolters Kluwer Health: Lippincott

After healing, minor facial scars have little or no effect on ratings of attractiveness – while some scars are even linked to more favorable ratings, suggests a survey study in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.

   

Not for public release

This news release is embargoed until 23-Nov-2022 2:00 PM EST Released to reporters: 22-Nov-2022 11:55 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 23-Nov-2022 2:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2022 8:55 AM EST
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Accure Acne, Inc.

Accure Acne, Inc. (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today it has received FDA clearance for its Accure Laser™ System to treat mild to severe inflammatory acne vulgaris.

   
Newswise:Video Embedded how-to-treat-acne
VIDEO
Released: 17-Nov-2022 10:00 AM EST
How to treat acne
American Academy of Dermatology

Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. As your body’s largest organ, it’s important to take good care of your skin. In recognition of National Healthy Skin Month in November, a board-certified dermatologist from the American Academy of Dermatology offers tips to help treat acne.

Released: 14-Nov-2022 10:05 AM EST
Preventing the next pandemic: Leaders of Pacific Rim Universities meet in Bangkok, Thailand
Newswise

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

       
13-Nov-2022 10:00 AM EST
HSS Research Uncovers How UV Light Triggers Immune Activation and Disease Flares in Lupus
Hospital for Special Surgery

After sun exposure, people with systemic lupus erythematosus (SLE) frequently develop skin rashes, which often are accompanied by a flare of their overall disease. This connection between ultraviolet (UV) light and disease flares in lupus is well known, but the way in which UV exposure actually triggers the disease has been poorly understood.

Released: 10-Nov-2022 11:30 AM EST
Dermatology appointment leads to life-saving cardiac care
American Academy of Dermatology

Christopher Bengson MD, MHS, FAAD, a board-certified dermatologist for the Indian Health Service in Phoenix, Ariz., and a Commander in the U.S. Public Health Service, was named an American Academy of Dermatology Patient Care Hero for making a life-saving recommendation that prevented a heart attack in a psoriasis patient.

Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Released: 8-Nov-2022 11:55 AM EST
New Analysis Finds Belimumab Improves Cutaneous Lupus Erythematosus in Patients with or without SLE
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).

Released: 8-Nov-2022 11:35 AM EST
Artificial Intelligence Shows Potential for Accurate Assessment of Nailfold Changes in Systemic Sclerosis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that the Vision Transformer, an open-source computer vision algorithm, could detect changes in nailfold capillaroscopy images from systemic sclerosis patients.

Released: 8-Nov-2022 11:05 AM EST
Study Finds Gastrointestinal Symptoms in Systemic Scleroderma Unrelated to Disease-Specific Medications
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and worsening gastrointestinal symptoms in early systemic scleroderma.

Released: 7-Nov-2022 12:40 PM EST
Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease
Wiley

Although melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is evidence that more cases of melanoma are being overdiagnosed in patients who would never experience symptoms.

2-Nov-2022 10:15 AM EDT
Managing Eczema in Babies: Five Things to Know
McMaster University

Five key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.

Released: 3-Nov-2022 11:05 AM EDT
New ‘smart tattoos’ tackle tech challenges of on-skin computing
Cornell University

Researchers at Cornell University have come up with a reliable, skin-tight computing system that’s easy to attach and detach, and can be used for a variety of purposes – from health monitoring to fashion.

Released: 3-Nov-2022 11:00 AM EDT
MD Anderson Research Highlights for November 3, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

   
Released: 2-Nov-2022 11:30 AM EDT
American College of Rheumatology Educating Dermatologists and Nephrologists on Lupus Clinical Trials Racial Disparities
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.

Released: 2-Nov-2022 10:50 AM EDT
Diabetes and Your Skin
American Academy of Dermatology

Your skin is a window to your overall health, and what happens on your skin is often an indicator of what’s happening inside your body.

Newswise: Reprogramming of Immune Cells Shown to Fight Off Melanoma
Released: 31-Oct-2022 8:05 AM EDT
Reprogramming of Immune Cells Shown to Fight Off Melanoma
University of Bristol

A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma.

Newswise:Video Embedded how-to-treat-eczema-at-home
VIDEO
Released: 27-Oct-2022 1:30 PM EDT
How to Treat Eczema at Home
American Academy of Dermatology

ROSEMONT, Ill. (October 27, 2022) — Eczema, or atopic dermatitis, is a common skin condition affecting 1 in 10 Americans. Patients with eczema often experience itchy, dry, raw, and sensitive patches of skin, which greatly impacts their quality of life. As we wrap up Eczema Awareness Month, board-certified dermatologists provide easy steps you can take at home to ease your symptoms.

25-Oct-2022 11:00 AM EDT
Neoadjuvant Immunotherapy with Relatlimab and Nivolumab Is Safe and Effective in Stage III Melanoma
University of Texas MD Anderson Cancer Center

Giving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma before surgery was safe and completely cleared all viable tumor in 57% of patients in a Phase II study, researchers from The University of Texas MD Anderson Cancer Center reported in Nature.

Released: 25-Oct-2022 10:30 AM EDT
National Healthy Skin Month: Dermatologists Provide Tips on Caring for Your Skin, Hair, and Nails
American Academy of Dermatology

In recognition of National Healthy Skin Month in November, board-certified dermatologists are providing their top tips for caring for your skin, hair, and nails.

Released: 24-Oct-2022 3:55 PM EDT
Phase II clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer
Wiley

Numerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system’s response against various cancers.

Released: 20-Oct-2022 10:35 AM EDT
Single-Port Robotic Surgery Improves Patient Ratings of Scarring After Urologic Procedures
Wolters Kluwer Health: Lippincott

The use of next-generation, single-port surgical robots leads to improved cosmetic outcomes and patient perceptions of scarring after robotic kidney, bladder, or prostate surgery, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).

Released: 19-Oct-2022 12:00 PM EDT
MD Anderson Research Highlights for October 19, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a combination approach to overcome PARP inhibitor resistance in breast and ovarian cancers, a deeper understanding of STAT3 mutations as drivers of disease progression, insights into the “obesity paradox” in men with advanced melanoma, a prognostic model for rapidly progressing vestibular schwannoma, and a role for cellular trafficking proteins in creating a metastasis-promoting lung cancer microenvironment.

   
Newswise: 54 Mercy Medical Center Physicians Named Among Region's
Released: 19-Oct-2022 11:05 AM EDT
54 Mercy Medical Center Physicians Named Among Region's "TOP DOCTORS" in November 2022 Issue of BALTIMORE Magazine
Mercy Medical Center

A total of 54 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2022 “Top Doctors” issue, representing 28 separate specialties.

Released: 18-Oct-2022 11:05 AM EDT
Psoriasis does not appear to increase heart attack risk in people with significant kidney disease
Medical College of Georgia at Augusta University

Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.

Newswise: Chemist examines properties of tattoo inks
Released: 17-Oct-2022 2:05 PM EDT
Chemist examines properties of tattoo inks
Binghamton University, State University of New York

Researchers at Binghamton University, State University of New York are working to understand the molecular composition of tattoo inks to provide knowledge to artists and consumers.

Released: 12-Oct-2022 5:00 PM EDT
Dermatologists Taking Action to Solve the Access to Care Conundrum
American Dermatological Association

The American Dermatological Association affirms the pressing need to address the defects that exist in the current medical infrastructure which prevent equal access, and consequently equitable medical outcomes, for all patients with dermatologic disorders. Issues limiting access to dermatology care are highlighted here and should urgently be addressed.

Released: 12-Oct-2022 10:25 AM EDT
Dermatologists warn people about the reliability of online symptom checkers
American Academy of Dermatology

Thanks to the internet, we have the world at our fingertips, and with just a few clicks, we can easily enter our medical symptoms into websites and apps to self-diagnose illnesses. However, a new article published in the Journal of the American Academy of Dermatology reveals that online symptom checkers are often inaccurate in identifying skin rashes.

Newswise: Scientists are One Step Closer to Stopping Drug-Resistant Tumors from Growing
Released: 11-Oct-2022 5:05 PM EDT
Scientists are One Step Closer to Stopping Drug-Resistant Tumors from Growing
University of Utah Health

Researchers at Huntsman Cancer Institute have solved a long-standing mystery about how a cancer-promoting protein causes drug-resistent tumors to grow. They hope the discovery leads to more effective cancer drugs. Ben Myers, PhD, explains how this new science is closing the gap in understanding brain and skin tumors and how to combat them.

Released: 11-Oct-2022 4:15 PM EDT
Skin-stretching device shows promise for closing large scalp wounds
Wolters Kluwer Health: Lippincott

A new, creative and innovative, minimally invasive skin-stretching device provides a promising alternative for surgical treatment of large scalp defects, reports a paper in The Journal of Craniofacial Surgery. The journal, under the guidance of Editor-in-Chief Mutaz B. Habal, MD, FRCSC, is published in the Lippincott portfolio by Wolters Kluwer.

Released: 6-Oct-2022 3:05 PM EDT
Tofacitinib shows promise in scleroderma patients, researchers optimistic for next phase of study
Michigan Medicine - University of Michigan

The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and can possibly be repurposed for systemic sclerosis treatment.



close
6.10158